Australia, April 24 -- Terns Pharmaceuticals Inc., owns the trademark (2618898) for 'TERNS' and 'BIRD,STYLISED' till Nov. 12, 2035.
Status: protected:
Registered/protected
Classes: 5 [Pharmaceutical preparations, namely, small-molecule drugs for the treatment of cancer, metabolic disorders, and endocrine disorders; pharmaceutical and biologic preparations for use in the treatment of oncology-related diseases and disorders; pharmaceutical and biologic preparations for use in the treatment of metabolic-related diseases and disorders; pharmaceutical and biologic preparations for use in the treatment of endocrine-related diseases and disorders; pharmaceutical and biologic preparations for use in the treatment of diabetes and obesity-related diseases and disorders; peptides for pharmaceutical purposes, namely, for the treatment of cancer, metabolic disorders, and endocrine disorders.] and 42 [Pharmaceutical and biologic drug development services, namely, development of small-molecule drugs for use in humans; pharmaceutical and biologic drug development services, namely, development of pharmaceutical and biologic preparations for the treatment of oncology-related diseases and disorders; pharmaceutical and biologic drug development services, namely, development of pharmaceutical and biologic preparations for the treatment of metabolic-related diseases and disorders; pharmaceutical and biologic drug development services, namely, development of pharmaceutical and biologic preparations for the treatment of endocrine-related diseases and disorders; pharmaceutical and biologic drug development services, namely, development of pharmaceutical and biologic preparations for the treatment of diabetes and obesity-related diseases and disorders; research and development services in the field of pharmaceutical and biologic preparations; research and development services in the field of oncology-related diseases and disorders; research and development services in the field of metabolic-related diseases and disorders; research and development services in the field of endocrine-related diseases and disorders; research and development services in the fields of diabetes and obesity-related diseases and disorders; research and development services in the field of peptide pharmaceutical preparations; providing medical and scientific research information in the field of small-molecule drugs; providing medical and scientific research information in the field of clinical trials and post-market trials; providing medical and scientific research information in the field of oncology, metabolic, endocrine, diabetes, and obesity-related diseases and disorders.]
Type of Mark: Figurative
Date of Acceptance: Feb. 16
Registration Advertised: April 23
For further details contact Tiffany D. Gehrke Marshall, Gerstein & Borun LLP .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2618898.
Disclaimer: Curated by HT Syndication.
